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into a 50-mL         volume of broth reduces the
concentration of inhibitory factors, facilitating
isolation of the organism (4).
In 1993, we reported results of routine use of
blood-culture bottles for processing cultures of
exudates (7) at the Soroka University Medical
Center, Beer-Sheva, Israel. From 1988 to 1992,
25 children with invasive K. kingae infections,
defined as isolation of the organism from blood or
normally sterile body fluids, were identified in
southern Israel. From 1994 to 1998, 33
additional patients, including 32 children and a
21-year-old adult, were detected in the same
area. Twenty-four (63.6%) of the 33 patients
were male. Eight (24.2%) cases were diagnosed
between January and June and 25 (75.8%)
between July and December. Median age of
children was 13 months (mean ± SD: 15.0 ± 7.6
months; range 6 to 37 months).
The fact that all children in southern Israel
are born and receive inpatient medical services
at the Soroka University Medical Center allowed
us to calculate the incidence of invasive pediatric
K. kingae infections in this population. During
the 6-year period, the average annual number of
births was 10,860. The annual incidence of
invasive  K. kingae infections during the same
period was 11.9 per 100,000 in children
< 48 months of age, 19.2 per 100,000 in children
<24 months of age, and 20.0 per 100,000 in
infants <12 months of age.
When medical attention was sought, patients
had been ill for a median of 3 days. Symptoms of
upper respiratory tract infection were recorded
in 12 (36.4%) children, stomatitis in 8 (24.2%),
and diarrhea in 4 (12.1%). Occult bacteremia
(positive blood culture with no obvious focal
infection) was diagnosed in 16 children. In 15
children,  K. kingae had invaded the bones. Septic
arthritis was diagnosed in 11 children, involving
the ankle in 4; the knee or wrist in 2 patients
each; and the hip, shoulder, or elbow in one
patient each. Osteomyelitis was diagnosed in two
patients, affecting the femur in one and the tibia
in the other. In two additional patients, both
with fever and bacteremia, the location of the
skeletal infection could not be determined. One
limped and had tenderness over the femur, but
X-rays and a Technecium99-labeled bone scan
showed no abnormalities. The other had pain in
the heel but no fluid could be aspirated.
Bacteremic tracheobronchitis occurred in one
child, and endocarditis of the mitral valve was
diagnosed in a 21-year-old woman who was
receiving immunosuppressive therapy for
systemic lupus erythematosus. All 33 patients
were treated with ß-lactam drugs and recovered.
Injecting synovial fluid specimens into blood-
culture bottles permitted the diagnosis of
K. kingae in these patients and showed that this
organism may be a common cause of invasive
pediatric infections. The age distribution of the
patients demonstrates that K. kingae is a
pathogen of young children, especially those
between the ages of 6 months and 2 years, among
whom the incidence of invasive disease has
remained stable since 1988. This age distribution
of  K. kingae infections parallels that for
respiratory carriage of the organism. In a
surveillance study among 48 children ages 6 to
42 months attending a day-care center in Israel,
K. kingae was isolated from 109 (17.5%) of 624
throat cultures, and 34 children (70.8%) carried
the organism at least once during an 11-month
period (8). However, the organism was not
detected in healthy infants ages 2 to 4 months
attending a well-baby care clinic, which indicates
some immunity to colonization and infection by
K. kingae during the first months of life (8).
When the 1988 to 1993 surveillance data are
added to those collected from 1994 to 1998,
K. kingae infections show a significant seasonal
pattern; 44 (75.9%) of 58 cases were diagnosed in
the second half of the year (p = 0.007). This
increase in K. kingae infections in winter has
also been described in other respiratory
pathogens. This finding, as well as the frequent
detection of respiratory symptoms in children
with invasive K. kingae infections, suggests that
seasonal viral infections may facilitate the
spread of K. kingae from the throat, to the
bloodstream and bones. In a prospective study,
K. kingae bacteremia was documented in 4
(13.7%) of 29 young children with culture-proven
herpetic gingivostomatitis, confirming the role
played by viral infections in the pathogenesis of
infections caused by the organism (9).
With few exceptions, isolates of K. kingae
remain susceptible to antibiotic drugs (10). Our
results demonstrate that the prognosis of
invasive  K. kingae infections is generally good
and patients respond promptly to appropriate
antimicrobial therapy.87 87 87 87 87 Vol. 6, No. 1, January–February 2000 Emerging Infectious Diseases
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Involving Ornithologists in the
Surveillance of Vancomycin-Resistant
Enterococci
To the Editor: Because migratory birds cross
national or intercontinental borders, they are
possible long-range vectors for human pathogens
such as viruses, Borrelia burgdorferi sensu lato,
and enteropathogenic bacteria with antibiotic
resistance or virulence factors (1,2). Enterococci
are ubiquitous in humans and animals and have
a propensity for uptake and transfer of
glycopeptide antibiotic resistance (3); therefore,
the emergence of glycopeptide-resistant entero-
cocci (GRE) in humans is a public health concern.
Low-level vancomycin resistance (genotype
vanC-1-3) is intrinsic in enterococcal species
(e.g., Enterococcus gallinarum, E. flavescens,
and E. casseliflavus) that may normally occur in
the intestinal flora of some birds. However, the
finding of high levels of GRE in wild birds suggests
acquisition from an environmental source.
In March 1998, we obtained fecal samples
while banding 318 northbound         migrating gulls
in Malmö, southern Sweden. Using a selective
culture procedure with enrichment broth (bile
esculin azide broth, Acumedia, LabFab, Ljusne,
Sweden) containing vancomycin (8 µg/ml) and
aztreonam (60 µg/ml), we isolated vancomycin-
resistant E. faecalis from a black-headed gull
(Larus ridibundus). High-level glycopeptide resis-
tance (>256 µg/ml) was demonstrated by E-test
(AB Biodisc, Solna, Sweden), and a vanA
genotype was found by polymerase chain reaction
amplification (4). This survey protocol can also be
used to detect medium to low levels of glycopeptide
resistance. Using the same procedure in a study
of 230 sub-Antarctic birds on Bird Island, South
Georgia, in 1996, we found four GRE isolates with
vanC1 genotype (MIC 3-8 µg/ml).
Many species of gulls have moved into urban
areas, where they commonly feed on human
trash and deposit feces. The black-headed gull
with GRE described above was banded as a
fledgling in Malmö in 1995. Birds of this
population spend the winter mainly in Western
Europe (5), where they forage at garbage dumps,
sewage outlets, and agricultural areas. This bird
may have acquired GRE in such an area. VanA
genotype E. faecium and E. faecalis have been
found in poultry and pigs in the Netherlands and
Denmark, where the vancomycin analog avoparcin
has been used as a growth promoter (6). Manure
from such farms may be a GRE source accessible
to wild birds.
We have previously reported the introduc-
tion into Sweden of multidrug-resistant Salmo-
nella Typhimurium by migratory birds (7). The
present report further emphasizes the possibility
of migratory birds as long-range vectors of
bacteria potentially associated with human
disease. The risk to humans for GRE from
migratory birds may seem insignificant com-
pared with such risk from hospitalization or from
eating meat products from GRE-colonized